Litigation Update: Zantac Contamination

According to a recent FDA announcement, a probable human carcinogen has been found in some ranitidine heartburn medications, including brand name Zantac, and the FDA is investigating the possible source of contamination. The substance is NDMA (N-Nitrosodimethylamine), the same contaminant that lead to recalls of blood pressure and heart failure medications such as Valsartan over the last year.

Several companies responded at first with a voluntary distribution halt, but at least one has now issued a recall. Sandoz, the generic division of Novartis, has issued a recall for all lots of its 150 mg and 300 mg ranitidine hydrochloride capsules “because of confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by the FDA.” GlaxoSmithKline has suspended supply of the drug worldwide, as has Dr. Reddy’s Laboratories. Sanofi, the producer of Zantac, has not halted sales of the brand name product at this time.

Health Canada has requested that all companies stop distributing ranitidine drugs in Canada while it investigates NDMA. Some countries in the European Union are recalling ranitidine containing an active ingredient made by an India-based manufacturer, Saraca Laboratories, after the facility received a notice from the European Directorate for the Quality of Medicines that its certificate of suitability for ranitidine hydrochloride had been suspended with immediate effect. Saraca also is registered with the FDA to make active ingredients for medicines taken by American consumers.

Ranitidine is an over-the-counter (OTC) and prescription drug. It is a histamine-2 blocker, which decreases the amount of acid created by the stomach. Ranitidine OTC is used to prevent and relieve heartburn associated with acid ingestion. Prescription ranitidine is approved for multiple indications, including treatment and prevention of ulcers of the stomach and intestines and treatment of gastroesophageal reflux disease (commonly known as GERD).

READ  The Dicamba Papers: Key Documents and Analysis

Click on this link for information on Verus’ Case Management and Medical Review Services. To contact us, fill out this form or email us at info@verusllc.com and we will reply immediately.

|CONTACT US| |REQUEST PROPOSAL|

V.P. of Mass Torts Services, General Counsel
dzonies@verusllc.com
609-466-0427

Deb is a lawyer with over 25 years of legal and business experience. As the leader of mass tort services at Verus, she oversees the support services provided to law firms involved in mass tort litigation, specifically in the areas of case management, claimant contact and medical record review. More

Spread the love

Author: Edward Lott

Edward Lott, Ph.D., M.B.A. is President and Managing Partner of Allentown-based ForLawFirmsOnly Marketing, Inc., a client acquisition company that offers attorneys signed client cases.Ed has been a digital entrepreneur since 1994, having discovered very early the opportunities the Internet offered. After having spent over two decades helping small business owners, Ed joined the staff of ForLawFirmsOnly Marketing as President and Managing Partner, where he is expanding the agency's cutting-edge services.A true marketing futurist, Ed's vast experience working directly with attorneys has given him a unique perspective on law firm marketing not found in many other digital marketing agencies. Ed has reshaped the offerings of ForLawFirmsOnly to focus on growing law firms through a holistic approach to digital marketing evident in the reformulated lead generation processes now in place. He is taking that same holistic approach for small businesses, helping them grow their bottom line.Want to learn more about ForLawFirmsOnly Marketing, our client acquistion services or lead generation programs, or just talk to Ed about his visions for helping your business grow? Call him at 855-943-8736.

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved